COMMUNIQUÉS West-GlobeNewswire

BeyondSpring Summarizes Key Messages from KOL Call regarding Lead Asset Plinabulin for the Prevention of Docetaxel Chemotherapy-Induced Neutropenia
05/02/2018
NEW YORK , Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transforming immuno-oncology cancer therapies, today [...]
Anthera Concludes Last Patient Visit in the Phase 3 RESULT Clinical Study of Sollpura
05/02/2018
HAYWARD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) is pleased to announce that the final patient has completed the last visit in the primary treatment phase of RESULT, a [...]
Canada House Wellness Group Now Included in the Emerging Marijuana ETF
05/02/2018
TORONTO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has been included in an Electronic Trading Fund “ETF” the Emerging [...]
ICYMI - Premier Biomedical CEO Interviewed on Fox Business “New To The Street” Program
05/02/2018
JACKSON CENTER, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) President and CEO, William A. Hartman was interviewed by host, Ken Evseroff, on the program “New To The Street”, which aired on [...]
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
05/02/2018
SHANGHAI, China and CUPERTINO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG ) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of immunotherapies [...]
Cancer Genetics, Inc. Chief Executive Officer Steps Down
05/02/2018
• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ) an emerging leader in enabling precision medicine for oncology [...]
Sorrento Therapeutics, Inc. Chairman/CEO letter to stockholders
05/02/2018
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Dear Sorrento Stockholders, Since its inception in 2006, Sorrento Therapeutics, Inc. (“Sorrento”) has continued to evolve as a dynamic, forward-focused biopharmaceutical [...]
BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University
05/02/2018
CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a Laboratory Service [...]
Vericel to Present at the BIO CEO & Investor Conference
05/02/2018
CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, [...]
Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma
05/02/2018
EXTON, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Bio-Path Holdings Appoints Paul Aubert to its Board of Directors
05/02/2018
HOUSTON, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Genitourinary Cancers (ASCO GU) 2018 Annual Meeting
05/02/2018
ROCKVILLE, Md., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]
David Taing, MD, DC, CAQSM is Elected to the American Health Council’s Board of Physicians
05/02/2018
NEW YORK, Feb. 05, 2018 (GLOBE NEWSWIRE) -- The American Health Council has elected David Taing, MD, DC, CAQSM, to its Board of Physicians. He is currently a Hospital-Employed Physician and Medical Director of two [...]
Pain Therapeutics Reports 2017 Financial Results and Corporate Update
05/02/2018
– 2018 Focus will be on REMOXY, Fiscal Discipline and Advancing Pipeline – AUSTIN, Texas, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) today reported financial results for the year ended [...]
Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations
05/02/2018
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]
Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Monoclonal Antibody in South Korea
05/02/2018
SEOUL, South Korea and SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Effective February 5th, 2018, Yuhan Corporation (KRX:000100.KS) (Yuhan) and Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) (Sorrento) announce that the [...]
PositiveID’s Chief Science Officer Discusses Company’s Detection of Flu Virus on its FireflyDX Prototype in Interview with CEOLIVE.TV
05/02/2018
DELRAY BEACH, Fla., Feb. 05, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (the “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, and its ExcitePCR subsidiary announced today that [...]
Radient Technologies Inc. Announces Approval and Receipt of Controlled Drugs and Substances Licence from Health Canada
05/02/2018
EDMONTON, Alberta, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V: RTI ) is pleased to announce that its application for the Controlled Drugs and Substances Licence has [...]
RavenQuest Asked to Be a Primary Resource for Assembly of First Nations in Saskatchewan
05/02/2018
VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is proud to announce that it will be working with First Nation communities from across [...]

Pages